Stéphane Bancel (Photo: Jeff Rumans for Endpoints News)
Merck drops out of a $125M KRAS alliance with Moderna, taking a step away from the Covid-19 star
Four years ago, Merck’s Roger Perlmutter lined up to pay Moderna an extra $125 million for preferred equity to gain rights to its early stage …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
